Medical and Radiation Oncology
Medical oncologists with special interest in lung cancer offer a full range of chemotherapy and biologic targeted therapies for all types and stages of lung cancer. Patients have access to the latest therapies and clinical trials. When appropriate, patients are placed on a clinical pathway, a disease-specific treatment strategy developed by UPMC CancerCenter physicians, to ensure that all patients receive the same evidence-based care. Thoracic clinic director, Jan Rothman, MD, plays a key role in pathway development and ongoing review helping to ensures that each pathway remains the best and most effective treatment option available. Innovative and promising clinical trial options are pursued along with the best standard of care therapies.
Our Lung Cancer Medical Oncologist and Clinic Director
Radiation oncologists at The Regional Cancer Center are experienced in the use of conventional radiotherapy, 3D radiotherapy, intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT). The Trilogy radiation delivery system used at the Center is one of the most advanced available. The Regional Cancer Center also uses positron emission tomography (PET) along with computed tomography (CT) imaging technologies when appropriate to trace the tumor through every point of the breathing cycle to more precisely target radiation during treatment. This optimizes the dose of radiation to the tumor while sparing healthy surrounding tissue from the effects of the radiation.
Stereotactic radio surgery and stereotactic body radiotherapy (SBRT) leverage the capability of the Center’s Trilogy radiation delivery system to treat tumors in the lung without having to make an incision. This procedure is generally reserved for people who cannot have surgery because of age, lung disease or heart disease. Trilogy radiosurgery has the capability of acquiring a CT scan of the tumor immediately before, during, and after each treatment to further ensure the accurate targeting of tumors.